Nat Commun. 2019 May 20;10(1):2238. doi: 10.1038/s41467-019-09831-5.

Functional cardiac fibroblasts derived from human pluripotent stem cells via second heart field progenitors.

Zhang J^1,2, Tao R³, Campbell KF^4,5, Carvalho JL^3,6, Ruiz EC³, Kim GC³, Schmuck EG³, Raval AN³, da Rocha AM^4,5, Herron TJ^4,5, Jalife J^4,7, Thomson JA^8,9, Kamp TJ^10,11,12.

Abstract

Cardiac fibroblasts (CFs) play critical roles in heart development, homeostasis, and disease. The limited availability of human CFs from native heart impedes investigations of CF biology and their role in disease. Human pluripotent stem cells (hPSCs) provide a highly renewable and genetically defined cell source, but efficient methods to generate CFs from hPSCs have not been described. Here, we show differentiation of hPSCs using sequential modulation of Wnt and FGF signaling to generate second heart field progenitors that efficiently give rise to hPSC-CFs. The hPSC-CFs resemble native heart CFs in cell morphology, proliferation, gene expression, fibroblast marker expression, production of extracellular matrix and myofibroblast transformation induced by TGFβ1 and angiotensin II. Furthermore, hPSC-CFs exhibit a more embryonic phenotype when compared to fetal and adult primary human CFs. Co-culture of hPSC-CFs with hPSC-derived cardiomyocytes distinctly alters the electrophysiological properties of the cardiomyocytes compared to co-culture with dermal fibroblasts. The hPSC-CFs provide a powerful cell source for research, drug discovery, precision medicine, and therapeutic applications in cardiac regeneration.